Nanocrystals and Microparticles to Treat Osteoarthritis
September 4, 2018 | Terry Sharrer
The ancient Greeks who coined the phrase “misery loves company” may well have been talking about osteoarthritis—an affliction that today accounts for 80% of people over age 75. Therapy to date has not been very effective; however, chemists at the University of Geneva may have a breakthrough. They crystalized the cartilage regenerating molecule kartogenin and encapsulated it in microparticles which they then injected into damaged joints. The particles act as “ball bearings” while cartilage regeneration progresses. In animal studies the particles did not cause further inflammation. MORE
Image Credit: Pixabay